Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
(NASDAQ: LEGN) Delayed: 35.87 -0.41 (1.13%)
Previous Close $36.28    52 Week High $ 
Open $36.22    52 Week Low $ 
Day High $36.85    P/E N/A 
Day Low $34.88    EPS $ 
Volume 1,700,479